Summary

PRA’s comprehensive Phase I facilities support global human abuse potential studies. Our expert teams work with clients who are developing CNS compounds to incorporate critical regulatory decisions and requirements as early as possible into their clinical development programs.

Register to download

Human Abuse Potential